Hematology & Blood Cancer
Care teams at Thomas Jefferson University Hospital decreased time to chemotherapy administration by using new strategies.
ICANS, a complication of CAR T cell therapy, was associated with an injury that is detectable with a blood test.
The tablet form of blood cancer drug acalabrutinib has been FDA approved, making administration easier for certain patients.
One concern that keeps patients from enrolling in clinical trials is the belief that their quality of life will suffer.
Patients who receive a transplant at a young age may experience GVHD symptoms decades later, like oral chronic GVHD.
Anti-thymocyte globulin (ATG) is used in conditioning prior to allogeneic hematopoietic stem cell transplantation for acute ...
Pivotal trials that supported FDA approval of CAR T-cell therapies had low proportions of Black patients enrolled.
These findings were presented at the 2021 American Society of Hematology Annual Meeting.
Polatuzumab Vetodin Plus R-CHP Reduces Risk of Disease Progression or Death in Newly Diagnosed DLBCL
Hervé Tilly, MD, of Centre Henri Becquerel and University of Rouen in France, presented the new research at ASH 2021.
This lack of benefit was seen in the entire study population.
eripheral blood cytopenias may be associated with a higher risk of cancer-related mortality, particularly in Black patients.
This is according to preliminary data from a nonrandomized arm of the SEQUOIA trial.
The CAR T-cell therapy significantly improved event-free survival (EFS) compared with standard of care in patients with LBCL.
According to new research, circulating tumor DNA (ctDNA) accurately reflects tumor burden.
Investigator L. Elizabeth Budde, MD, PhD, presented the research at the 2021 ASH Annual Meeting.
“The results of ZUMA-7 herald a paradigm shift in how we treat large B-cell lymphoma."
Researchers, led by Katharine McLaughlin, examined the relationship between changes in vital signs and admission to an ...
Researchers performed a meta-analysis to evaluate two hypomethylating agents (HMAs), decitabine and azacitidine, in the ...
Findings from a randomized trial, published in The Lancet Oncology, showed that combining enasidenib with azacitidine was ...
Researchers developed a method to measure standardized intracellular reactive oxygen species (siROS) levels in the CD34+ bone ...
670 Madison Ave.
Manalapan, NJ 07726
© 2022 Mashup Media, LLC. All rights reserved.